4/A//SEC Filing
Recro Pharma, Inc. 4/A
Accession 0001192482-15-000321
CIK 0001588972operating
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 3:51 PM ET
Size
7.9 KB
Accession
0001192482-15-000321
Insider Transaction Report
Form 4/AAmended
Garner Charles
CFO and Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2015-07-25+23,000→ 23,000 totalExercise: $2.47Exp: 2024-12-17→ Common Stock (23,000 underlying) - Award
Employee Stock Option (right to buy)
2014-12-17+23,000→ 23,000 totalExercise: $2.47Exp: 2024-12-17→ Common Stock (23,000 underlying)
Footnotes (3)
- [F1]The option vests monthly in equal proportions over a period of four years beginning on December 17, 2014.
- [F2]Amended to reflect correct transaction date.
- [F3]The option was granted on December 17, 2014 and vests 30% upon satisfaction of certain performance conditions, and then monthly thereafter in equal proportions over a three-year period beginning on the date the performance conditions are satisfied. On July 25, 2015 the Compensation Committee of the Board of Directors of the Issuer determined that the performance criteria were met, resulting in vesting of 30% of the option and the beginning of the three-year monthly vesting period.
Documents
Issuer
Recro Pharma, Inc.
CIK 0001588972
Entity typeoperating
IncorporatedPA
Related Parties
1- filerCIK 0001588972
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 3:51 PM ET
- Size
- 7.9 KB